Covid: Biden vows 100m vaccinations for US in first 100 days

[ad_1]

media captionFauci: ‘We need to be transparent and articulate on the vaccine’

US President-elect Joe Biden has set a goal of 100 million Covid vaccinations in his first 100 days in office.

He said his first months in office would not end the outbreak but could change its course and change life.

Introducing his health team for when he takes office on 20 January, Mr Biden repeated that he would ask Americans to “mask up for 100 days”.

On Tuesday, a report paved the way for a Pfizer/BioNTech vaccine to be approved and rolled out for Americans.

President Donald Trump meanwhile attended a summit at the White House of his Covid vaccination programme called Operation Warp Speed and hailed the expected approval of vaccines.

  • Safety data on Pfizer jab released by US

  • How many doses will be given to each US state
  • Where has been hit hardest?

The US has recorded more than 15 million cases of infection in the pandemic so far and 285,000 deaths, according to Johns Hopkins University research, both global highs.

Many parts of the country are seeing peak infections, with record numbers of people in hospital, with some experts blaming travel by millions over the recent Thanksgiving holiday.

What has Biden said?

The president-elect was attending a press conference in Delaware during which he introduced California Attorney General Xavier Becerra as his nomination for health secretary and his choice of Rochelle Walensky as head of the Centers for Disease Control and Prevention (CDC).

Joe Biden

image copyrightReuters

image captionJoe Biden introduced his new health team in Delaware on Tuesday

Mr Biden said: “My first 100 days won’t end the Covid-19 virus. I can’t promise that. But we did not get into this mess quickly. We’re not going to get out of it quickly.”

He said in the first “100 days we can change the course of the disease and change life in America for the better”.

But he warned that the coronavirus efforts could “slow and stall” if Congress did not conclude bipartisan talks and urgently come up with funding.

Getting children back to school would also be a priority, he said.

Among Mr Biden’s other aides will be Dr Anthony Fauci as chief Covid medical adviser. The infectious diseases expert also advised the Trump team – and often fell foul of the president for his views.

What happened at the White House?

It was mainly a celebration of Operation Warp Speed’s efforts to get a vaccine to the American people. Any rollout of the largest vaccination programme in US history will be carried out by the Biden team.

media captionTrump: “Every American who wants the Covid vaccine will get it”

President Trump said of the expected vaccine approvals: “They say it’s somewhat of a miracle and I think that’s true.”

He added: “Every American who wants the vaccine will be able to get the vaccine and we think by spring we’re going to be in a position nobody would have believed possible just a few months ago.”

The Trump administration hopes to vaccinate as many as 24 million people by mid-January.

The president also signed an executive order aimed at ensuring that Americans had first priority in receiving doses – a move that appeared to follow his longstanding America First policy.

But how it will affect contracts that US companies have already signed with other countries remains unclear.

image copyrightReuters
image captionA billboard outside the Pfizer HQ in New York

Mr Trump’s administration did sign up for an initial 100 million doses of the Pfizer/BioNTech vaccine but a member of the Pfizer board said the chance to buy more was turned down a number of times and more than the 100 million might not be available until June.

The Operation Warp Speed team said its policy was to deal with a number of manufacturers of vaccines.

Some in the US media said the executive order reflected concern that supplies might not be enough.

Where is the US with vaccination?

US regulators on Tuesday confirmed the Pfizer/BioNTech Covid vaccine was 95% effective, paving the way for it to be approved for emergency use.

The Food and Drug Administration (FDA) found no safety concerns to stop approval of the vaccine and meets on Thursday to make a formal decision.

Although two doses are needed to offer full protection, the first jab prevented 89% of the most severe cases.

Some side-effects such as redness or swelling at the injection site, short-term fatigue, headaches and muscle-pain were reported but were considered mild.

US biotech firm Moderna has reported similar successes with its vaccine and it is also expected to get FDA approval before Christmas.

Related Topics

[ad_2]

Source link

Add a Comment

Your email address will not be published. Required fields are marked *